Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1272 Two-year experience of BITOX: the Belgian multidisciplinary ImmunoTOXicity board, a nationwide initiative of the Belgian Society for Medical Oncology (BSMO)
Compose a Response to This Article
Other responses
No responses have been published for this article.
